Paul has 34 years of experience in the pharmaceutical and biotech industry, and has worked in preclinical microbiology, anti-infective and oncology clinical research, project management, and managed a Phase I Research Clinic. He has previously worked at Warner-Lambert/Parke-Davis, DepoTech, Agouron, Pfizer, Trius Therapeutics, Progenity, and Amplyx Pharmaceuticals, Inc. While at Pfizer he served as a Research Team Leader and Exploratory Development Director leading several oncology drug development teams. He has been involved in a number of successful drug development programs including Penetrex®, Sparfloxacin®, Cefzon®, Viracept®, Sutent®, Inlyta®, and Sivextro®. Paul received his B.S. in Microbiology and Public Health from Michigan State University and his M.S. from the University of Michigan in Clinical Trial Design and Statistical Analysis.
Ed Castellana, PhD., is Senior Director of Product development at Sienna Biopharmaceuticals Inc. (Sienna). Prior to its acquisition by Sienna, Ed was head of R&D and member of the management team at Sienna Labs, Inc. where he was responsible for advancing the development of two topical products based on the science of plasmonic resonance through early stage clinical development into pivotal trials. Additionally, Ed oversaw the development of a transdermal delivery device and managed the production and distribution of clinical supply. With over 10 years of industry experience, his career encompasses a wide range of R&D and leadership activities centered on early product development in the medical device and diagnostics industries. Prior to Sienna, Ed has held R&D positions with several startups focused on developing biosensor platforms and devices for the healthcare sector, was a Research Professor at the University of Texas at Dallas, and a Postdoctoral Fellow at Texas A&M University. Ed received a BS in Mathematical Physics and Chemistry from SUNY Fredonia and a PhD in Chemistry from Texas A&M University.
Michelle Higginson, RDN, CD